AbbVie stock fell Friday after the pharma company reported adjusted earnings of $3.11 per share on $13.96 billion in second-quarter sales.
In the year-earlier period, AbbVie earned $2.34 per share and reported $10.43 billion in sales.
For the year, AbbVie expects per-share earnings of $12.52-$12.62 vs. its prior target of 12.37-$12.57, lifting the midpoint by a dime to $12.57. Analysts called for profit of $12.60 per share and $55.91 billion in sales.
Follow Allison Gatlin on Twitter at @IBD_AGatlin.
YOU MAY ALSO LIKE: